𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection

✍ Scribed by Jia-Horng Kao; Pei-Jer Chen; Ming-Yang Lai; Ding-Shinn Chen


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
65 KB
Volume
68
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Although occult hepatitis B virus (HBV) infection in individuals without detectable hepatitis B surface antigen (HBsAg) may occur and has been reported to be common in patients with chronic hepatitis C, the related molecular mechanisms remain unknown. With the polymerase chain reaction, serum HBV DNA was sought in 100 HBsAg-negative patients with chronic hepatitis C virus (HCV)-infection. In those with occult HBV infection, possible genomic variability of HBV was evaluated by amplification and direct sequencing of pre-S, surface, and pre-core/core promoter genes. In total, 10 of the 100 patients (10%) had detectable serum HBV DNA, documenting an occult HBV infection. A deletion mutant in the pre-S gene was found in one patient and mutations of the a determinant of HBsAg were observed in 2. In addition, a novel core promoter mutant (a dinucleotide substitution: T-to-C at nucleotide 1,802 and T-to-G at nucleotide 1,803, T1802C/T1803G) was found frequently in patients with occult HBV infection as compared to sex- and age-matched HBsAg-positive patients (80 vs. 10%, P < 0.001). In conclusion, the data suggest occult HBV infection is not uncommon in chronic hepatitis C patients in Taiwan, and a novel core promoter mutant may be associated with the absence of circulating HBsAg in these patients.


πŸ“œ SIMILAR VOLUMES


Complete genome sequence and phylogeneti
✍ Zagaa Odgerel; Kyung Bo Nho; Ju Young Moon; Sun Ho Kee; Kwang Sook Park; Ki-Joon πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract Although there is a report of high rate of hepatitis B virus (HBV) infection in South Korea, only a few entire genome sequences of HBV isolates from Korea have been reported. To obtain the complete nucleotide sequence of the Korean HBV, viral DNA was extracted from sera of Korean patien

PreS deletion mutations of hepatitis B v
✍ Xiangyan Huang; Yanghua Qin; Peng Zhang; Gusheng Tang; Qingfen Shi; Jun Xu; Fali πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 232 KB πŸ‘ 2 views

Hepatitis B surface antigen (HBsAg) and anti-HBs antibodies (anti-HBs) may coexist in certain chronic hepatitis B (CHB) patients. This study was designed to further explore the relationship between this coexistence and hepatitis B Virus (HBV) preS deletions. Sera of 28 patients carrying both HBsAg a

Detection of mutations in the enhancer 2
✍ Honda, Arata; Yokosuka, Osamu; Ehata, Toshiki; Tagawa, Masami; Imazeki, Fumio; S πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 3 views

To investigate the meaning of the mutations in the enhancer 2/core promoter (Enh2/CP) region of hepatitis B virus (HBV) during the chronic HBV infection, mutations were examined in the Enh2/ CP region (carboxyl half of X region) and their correlation with mutations in the precore and core regions in

Clinical features and prognosis of hepat
✍ Han Jak Ryu; Do Young Kim; Jun Yong Park; Hye Young Chang; Myoung Ha Lee; Kwang- πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 135 KB πŸ‘ 1 views

## Abstract Few studies have reported on the clinical characteristics of hepatocellular carcinoma (HCC) at the time of diagnosis with regard to pre‐S and basal core promoter (BCP) mutations. In this study, the clinical features and prognosis of 126 Korean HCC patients were examined with respect to

Impact of genetic polymorphisms near the
✍ Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Takahisa Kawaguchi; Yoshiki Mur πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 411 KB πŸ‘ 1 views

## Abstract It has been reported that genetic polymorphisms near the __IL28B__ gene or amino acid substitutions in hepatitis C virus (HCV) core protein are associated with the clinical outcome of peginterferon (PEG‐IFN) and ribavirin combination therapy. The impact of these factors on the pure sens